Category
ADC Therapy Antibody Therapy Cell & Gene Therapy Oncolytic Virotherapy Others Protein Therapy Small Molecule Vaccine
2025/11/13Flyer Cell & Gene Therapy
Based on a pioneering mRNA/LNP delivery platform, an in vivo anti-CD18/BCMA mRNA/LNP CAR-T is being developed for autoimmune diseases.
2026/01/10Flyer Cell & Gene Therapy
Dual-AAV vector-based gene therapies are currently undergoing clinical trials for various conditions, including ophthalmic, neuromuscular, and inherited metabolic diseases.
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.
 |
Protheragen Inc. |
 |
Quick Links |